Core Laboratories expects Reservoir Description revenues of $82-$85 million and Production Enhancement revenues of $39-$42 million for the first quarter of 2025.

Core Laboratories Inc (CLB) reports a 9% EPS increase for 2024, despite geopolitical and market challenges, while achieving the lowest leverage ratio in eight years.

Q4 2024 Earnings Call Transcript January 30, 2025 Operator: Good day, and welcome to the Core Laboratories’ Fourth Quarter ...

Check the time stamp on this data. Updated AI-Generated Signals for Core Laboratories Inc. (CLB) available here: CLB. Type a ...

Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to ...

Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ETCompany ParticipantsLarry Bruno - Chairman and Chief ...

Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 fourth-quarter conference call.

New data suggest venetoclax may offset the negative prognostic impact of short telomeres in patients with chronic lymphocytic ...

Stock analysts at Zacks Research lowered their Q3 2025 earnings per share (EPS) estimates for shares of Core Laboratories in a research note issued to investors on Friday, January 17th. Zacks Research ...

Stifel Nicolaus analyst Stephen Gengaro maintained a Hold rating on Core Laboratories (CLB – Research Report) yesterday and set a price target ...

New York improved to 5-0-2 in its last seven games and 6-1-2 overall in January. Daniil Tarasov had 26 saves and Columbus snapped a six-game winning streak. In the shootout, Trocheck scored on the ...